Action of some  -blockers on plasma fibrinolysis in vitro and in vivo in man.
D000319:Adrenergic beta-Antagonists / Q000145:classification / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D002082:Butylamines / Q000494:pharmacology; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D005916:Globulins; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology; D008297:Male; D000432:Methanol / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology; D010096:Oxprenolol / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002082:Butylamines; D005916:Globulins; D007211:Indoles; D009578:Nitrobenzenes; D010627:Phenethylamines; D013565:Sympatholytics; D013566:Sympathomimetics; D010096:Oxprenolol; D011433:Propranolol; D000432:Methanol